000			02143nas a22003615i 4500
001			1573-7365
003			DE-He213
005			20260610082526.0
007			cr nn 008mamaa
008			150723s||||||||xxuuu poo|||||| b|EN |d
022			_a1573-7365
024	7		_a10.1007/11011.1573-7365 _2doi
210	1	0	_aMetab Brain Dis
245	1	0	_aMetabolic Brain Disease _h[electronic resource] / _cedited by Liang Qiang.
264		1	_aNew York : _bSpringer US : _bImprint: Springer.
300			_bonline resource.
520			_aMetabolic Brain Disease serves as a forum for the publication of outstanding basic and clinical papers on brain diseases, including both human and animal studies. Topics include, but are not limited to, stroke, traumatic brain injury, myelin disorders, epilepsy, multiple sclerosis, toxic encephalopathies, genetic diseases affecting the brain, alcohol and brain metabolism, neuroendocrinopathies, viral and nonviral encephalitides, nutritional disorders affecting the brain, diseases affecting neurotransmitters, Alzheimer's disease, Parkinson’s disease, amyotrophic lateral sclerosis and aging. The journal publishes papers on the fundamental pathogenesis of these disorders and on related experimental and clinical techniques and methodologies. Metabolic Brain Disease is directed to neuroscientists, psychiatrists, neurologists, pathologists, and others involved in the research and treatment of a broad range of brain disorders. Founding Editor: David W. McCandless, MSc, PhD, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA .
650		0	_aNeurosciences.
650		0	_aNeurology .
650		0	_aDiseases.
650		0	_aBiochemistry.
650		0	_aOncology.
650	1	4	_aNeuroscience.
650	2	4	_aNeurology.
650	2	4	_aDiseases.
650	2	4	_aChemical Biology.
650	2	4	_aOncology.
700	1		_aQiang, Liang. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt
710	2		_aSpringerLink (Online service)
776	0	8	_iPrinted version: _x0885-7490
856	4	0	_uhttps://doi.org/10.1007/11011.1573-7365 _zHybrid
999			_c3932 _d3932